Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RSV-G inhibitors(RSV-G inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H37N6O10P |
InChIKeyCSCSSSMJOMHRRA-BBUFOYCLSA-N |
CAS Registry2694736-39-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respirovirus Infections | Preclinical | US | 19 Apr 2024 |